  | DEMARTEAU, C., PLEYERS, C., HERMESSE, J., Gennigens, C., Kakkos, A., Gonne, E., Goffin, F., & Kridelka, F. (September 2023). #749 Optimizing brachytherapy applicators implantation in locally advanced cervical cancer with transrectal ultrasound guidance. International Journal of Gynecological Cancer, 33, 91-A92. doi:10.1136/ijgc-2023-esgo.183  Peer reviewed |
  | Lucia, F., Bourbonne, V., PLEYERS, C., Dupré, P.-F., Miranda, O., Visvikis, D., Pradier, O., Abgral, R., Mervoyer, A., Classe, J.-M., Rousseau, C., Vos, W., HERMESSE, J., Gennigens, C., De Cuypere, M., Kridelka, F., Schick, U., Hatt, M., Hustinx, R., & Lovinfosse, P. (2023). Multicentric development and evaluation of 18F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06180-w Peer Reviewed verified by ORBi |
 | HERMESSE, J., PLEYERS, C., Gennigens, C., De Cuypere, M., Lovinfosse, P., Seidel, L., Coucke, P., & Kridelka, F. (2023). Outcome analysis of HDR compared to PDR IGABT in locally advanced cervical cancer: a single-center cohort analysis. Strahlentherapie und Onkologie. doi:10.1007/s00066-022-01982-7 Peer Reviewed verified by ORBi |
 | Dheur, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kridelka, F., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kakkos, A. (October 2022). 2022-RA-193-ESGO Cost-effectiveness of molecular profiling for endometrial neoplasia: a single institution experience [Poster presentation]. 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.203 Peer reviewed |
 | DHEUR, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kakkos, A., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kridelka, F. (29 September 2022). Defining prognostic risk groups amongst patients with endometrial cancer:respective role of 2009 figo stage and molecular profile [Poster presentation]. IGCS 2022, New York, United States. Peer reviewed |
 | De Cuypere, M., PLEYERS, C., HERMESSE, J., Lovinfosse, P., Delbecque, K., Gonne, E., Kakkos, A., Goffin, F., Kridelka, F., & Gennigens, C. (2022). A comparison of survival and recurrence pattern of patients presenting locally advanced cervical cancer according to the histological subtype: a monocentric retrospective study [Poster presentation]. 23rd European Congress on Gynecological Oncology, Berlin, Germany. Peer reviewed |
 | Colassin, A., Denis, C., HERMESSE, J., WALTREGNY, D., & SAUTOIS, B. (May 2021). Prise en charge d'un cancer de la prostate métastatique au diagnostic. Revue Médicale de Liège, 76 (5-6), 496-501. Peer reviewed |
 | LAPAILLE, L., DE CUYPERE, M., GOFFIN, F., KAKKOS, A., GONNE, E., HERMESSE, J., LOVINFOSSE, P., DELBECQUE, K., THILLE, A., Kridelka, F., & GENNIGENS, C. (2021). Cancer du col utérin localement avancé : approche multidisciplinaire. Revue Médicale de Liège, 76 (5-6), 507-514. Peer reviewed |
 | GENNIGENS, C., DE CUYPERE, M., HERMESSE, J., KRIDELKA, F., & JERUSALEM, G. (2021). Optimal treatment in locally advanced cervical cancer. Expert Review of Anticancer Therapy, 657-671. doi:10.1080/14737140.2021.1879646 Peer Reviewed verified by ORBi |
 | Da Silva Ferreira, M., LOVINFOSSE, P., HERMESSE, J., DE CUYPERE, M., Rousseau, C., Lucia, F., Schick, U., Reinhold, C., Robin, P., Hatt, M., Visvikis, D., Bernard, C., Leijenaar, R. T. H., Kridelka, F., Lambin, P., Meyer, P., & Hustinx, R. (2021). [(18)F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05303-5 Peer Reviewed verified by ORBi |
 | GENNIGENS, C., DE CUYPERE, M., HERMESSE, J., Barbeaux, A., Forget, F., KRIDELKA, F., & JERUSALEM, G. (February 2020). Impact of hemoglobin level and red blood cell transfusions in patients with locally advanced cervical cancer treated by chemoradiotherapy [Poster presentation]. 22nd Annual BSMO meeting, Gent, Belgium. |
 | Gennigens, C., DE CUYPERE, M., SEIDEL, L., HERMESSE, J., Barbeaux, A., Forget, F., Albert, A., Jerusalem, G., & Kridelka, F. (2020). Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy. Cancer Medicine, 1-12. doi:10.1002/cam4.3465 Peer Reviewed verified by ORBi |
 | DE CUYPERE, M.* , Lovinfosse, P.* , Gennigens, C., HERMESSE, J., Rovira, R., Duch, J., GOFFIN, F., Hustinx, R., & Kridelka, F. (2020). Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer. International Journal of Gynecological Cancer, 0, 1-8. doi:10.1136/ijgc-2020-001676 Peer reviewed* These authors have contributed equally to this work. |
 | GENNIGENS, C., KRIDELKA, F., JERUSALEM, G., SEIDEL, L., GOFFIN, F., Barbeaux, A., Forget, F., KAKKOS, A., HERMESSE, J., GONNE, E., & DE CUYPERE, M. (2019). Lymphocytes count at diagnosis is a potential survival predictor in patients treated by chemoradiation in locally advanced cervical cancer [Poster presentation]. ESGO 2019 Athens: 21st European Gynaecological Oncology Congress 2019, Athens, Greece. |
 | LAKOSI, F., DE CUYPERE, M., NGUYEN, V. P., JANSEN, N., WARLIMONT, B., GULYBAN, A., GENNIGENS, C., SEIDEL, L., DELBECQUE, K., COUCKE, P., HERMESSE, J., & KRIDELKA, F. (2015). Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients : a mono-institutional experience. Acta Oncologica, 54 (9), 1558-1566. doi:10.3109/0284186X.2015.1062542 Peer Reviewed verified by ORBi |
 | Doupagne, A., DE CUYPERE, M., KRIDELKA, F., GOFFIN, F., DELBECQUE, K., GENNIGENS, C., LAKOSI, F., KAKKOS, A., & HERMESSE, J. (September 2014). Parametrial boost does not replace optimal BT treatment in 102 patients with locally advanced cervical cancer (LACC) [Paper presentation]. ESGO, Torino, Italy. |
 | HERMESSE, J., WERENNE, X., PHILIPPI, S., & COUCKE, P. (2014). INDICATIONS D’UN TRAITEMENT DE RADIOTHERAPIE LOCALE APRES PROSTATECTOMIE RADICALE. Revue Médicale de Liège, 69 (Supp 1), 29-31. Peer reviewed |
 | HERMESSE, J., NICKERS, P., REUL, O., & COUCKE, P. (2014). LA CURIETHÉRAPIE PROSTATIQUE PAR IMPLANTS PERMANENTS D'IODE 125- résultats après 10 ans d'expérience au CHU de Liège. Revue Médicale de Liège, 69 (Supp 1), 32-36. Peer reviewed |
 | WERENNE, X., HERMESSE, J., PIRET, P., COUCKE, P., & KRIDELKA, F. (2012). Radiothérapie dans le cadre d’une maladie de Paget touchant la région génitale. Revue Médicale de Liège, 67 (2), 61-63. Peer reviewed |
 | Hermesse, J., Biver, S., JANSEN, N., LENAERTS, E., De Patoul, N., Vynckier, S., COUCKE, P., Scalliet, P., & Nickers, P. (2009). A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy. Strahlentherapie und Onkologie, 185 (11), 736-742. doi:10.1007/s00066-009-2009-5 Peer Reviewed verified by ORBi |
 | Hermesse, J., Thissen, B., Warlimont, B., Jansen, N., Coucke, P., & Niockers, P. (2008). Analysis of Dose Volume Histogram Differences between High Dose Rate Brachytherapy and Intensity Modulated Radiotherapy for Prostate Treatment. International Journal of Radiation, Oncology, Biology, Physics, 72 (1 (supplément)), 566. doi:10.1016/j.ijrobp.2008.06.140 Peer Reviewed verified by ORBi |
 | Hermesse, J., Devillers, M., Deneufbourg, J.-M., & Nickers, P. (March 2005). Can intensity-modulated radiation therapy of the Paraaortic region overcome the problems of critical organ tolerance? Strahlentherapie und Onkologie, 181 (3), 185-190. doi:10.1007/s00066-005-1324-8 Peer Reviewed verified by ORBi |